Miles Wang, a researcher at OpenAI, is leaving to launch a new startup focused on AI models for drug discovery, with potential to accelerate new treatments and therapies. Wang's venture may work on AI models to find new uses for existing drugs, reducing development time and cost. Read more...
Hashtags: #AIDrugDiscovery #LifeSciencesTech #OpenAIUpdates #NewsWave